Tag: HCPCS codes
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
How to Coordinate Care between OB/GYN and Psychiatrist for Medications During Pregnancy
May, 28 2026
Candidemia & Disseminated Candida Infections: Why Patient Education Matters
Oct, 21 2025
Biologic Patent Protection: When Biosimilars Can Enter the Market
Aug, 12 2026
Crossover Trial Design: How Bioequivalence Studies Are Structured
Dec, 15 2025
How the FDA Ensures Generic Drug Safety: A Look at Manufacturing Oversight
Apr, 30 2026